YAROSHEVSKY GLANVILLE MARY 4

4 · ANADYS PHARMACEUTICALS INC · Filed Jan 11, 2006

Form 4

Period: 2006-01-09

Vice President, Human Capital

Transactions

Exercise/Conversion
Common Stock
2006-01-09$2.95/sh+1,500$4,425→ 1,500 total
Sale
Common Stock
[F1]
2006-01-09$10.10/sh−600$6,060→ 900 total
Sale
Common Stock
[F1]
2006-01-09$10.13/sh−500$5,065→ 400 total
Sale
Common Stock
[F1]
2006-01-09$10.11/sh−300$3,033→ 100 total
Sale
Common Stock
[F1]
2006-01-09$10.15/sh−100$1,015→ 0 total
Sale
Common Stock
[F1][F2]
2006-01-09$10.22/sh−600$6,132→ 2,896 total
Sale
Common Stock
[F1]
2006-01-09$10.14/sh−570$5,780→ 2,326 total
Sale
Common Stock
[F1]
2006-01-09$10.15/sh−400$4,060→ 1,926 total
Sale
Common Stock
[F1]
2006-10-09$10.21/sh−200$2,042→ 1,726 total
Sale
Common Stock
[F1]
2006-01-09$10.16/sh−200$2,032→ 1,526 total
Sale
Common Stock
[F1]
2006-01-09$10.13/sh−200$2,026→ 1,326 total
Sale
Common Stock
[F1]
2006-01-09$10.20/sh−130$1,326→ 1,196 total
Sale
Common Stock
[F1]
2006-01-09$10.11/sh−81$819→ 1,115 total
Exercise/Conversion
Stock Option (Right to Buy)
[F3]
2006-01-09−1,500→ 5,363 total
Exercise: $2.95From: 2002-04-17Exp: 2011-06-20→ Common Stock (1,500 underlying)

Footnotes (3)

[F1]The reported sales were effected pursuant to a trading plan established under Rule 10b5-1 of the Securities and Exchange Act of 1934.
[F2]Includes 1,448 shares which were acquired pursuant to the Anadys Pharmaceuticals, Inc. 2004 Employee Stock Purchase Plan on November 15, 2004, includes 933 shares which were acquired pursuant to the Anadys Pharmaceuticals, Inc. 2004 Employee Stock Purchase Plan on May 15, 2005, and includes 1,115 shares which were acquired pursuant to the Anadys Pharmaceuticals, Inc. 2004 Employee Stock Purchase Plan on November 15, 2005.
[F3]The option vested and became exercisable over a period of four years. All shares subject to the option have vested and are exercisable as of the date of this filing.

Signature

/s/ Elizabeth E. Reed, as Attorney-in-Fact for Mary Yaroshevsky-Glanville|2006-01-11

Documents

1 file